BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26144885)

  • 1. AMPK Activation via Modulation of De Novo Purine Biosynthesis with an Inhibitor of ATIC Homodimerization.
    Asby DJ; Cuda F; Beyaert M; Houghton FD; Cagampang FR; Tavassoli A
    Chem Biol; 2015 Jul; 22(7):838-48. PubMed ID: 26144885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine models.
    Brooks HB; Meier TI; Geeganage S; Fales KR; Thrasher KJ; Konicek SA; Spencer CD; Thibodeaux S; Foreman RT; Hui YH; Roth KD; Qian YW; Wang T; Luo S; Torrado A; Si C; Toth JL; Mc Cowan JR; Frimpong K; Lee MR; Dally RD; Shepherd TA; Durham TB; Wang Y; Wu Z; Iversen PW; Njoroge FG
    Sci Rep; 2018 Oct; 8(1):15458. PubMed ID: 30337562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-glucose toxicity is mediated by AICAR-transformylase/IMP cyclohydrolase and mitigated by AMP-activated protein kinase in
    Riedinger C; Mendler M; Schlotterer A; Fleming T; Okun J; Hammes HP; Herzig S; Nawroth PP
    J Biol Chem; 2018 Mar; 293(13):4845-4859. PubMed ID: 29414769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The last enzyme of the de novo purine synthesis pathway 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC) plays a central role in insulin signaling and the Golgi/endosomes protein network.
    Boutchueng-Djidjou M; Collard-Simard G; Fortier S; Hébert SS; Kelly I; Landry CR; Faure RL
    Mol Cell Proteomics; 2015 Apr; 14(4):1079-92. PubMed ID: 25687571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia drives the assembly of the multienzyme purinosome complex.
    Doigneaux C; Pedley AM; Mistry IN; Papayova M; Benkovic SJ; Tavassoli A
    J Biol Chem; 2020 Jul; 295(28):9551-9566. PubMed ID: 32439803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.
    Li M; Jin C; Xu M; Zhou L; Li D; Yin Y
    Cell Commun Signal; 2017 Dec; 15(1):52. PubMed ID: 29246230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analyses of a purine biosynthetic enzyme from Mycobacterium tuberculosis reveal a novel bound nucleotide.
    Le Nours J; Bulloch EM; Zhang Z; Greenwood DR; Middleditch MJ; Dickson JM; Baker EN
    J Biol Chem; 2011 Nov; 286(47):40706-16. PubMed ID: 21956117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the de novo purine nucleotide pathway as a therapeutic strategy in mitochondrial myopathy.
    Kimoloi S
    Pharmacol Res; 2018 Dec; 138():37-42. PubMed ID: 30267763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis.
    Ma Z; Cools J; Marynen P; Cui X; Siebert R; Gesk S; Schlegelberger B; Peeters B; De Wolf-Peeters C; Wlodarska I; Morris SW
    Blood; 2000 Mar; 95(6):2144-9. PubMed ID: 10706887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CRISPR-Cas9 crATIC HeLa transcriptome: Characterization of a novel cellular model of ATIC deficiency and ZMP accumulation.
    Mazzarino RC; Baresova V; Zikánová M; Duval N; Wilkinson TG; Patterson D; Vacano GN
    Mol Genet Metab Rep; 2020 Dec; 25():100642. PubMed ID: 32939338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
    Marie S; Heron B; Bitoun P; Timmerman T; Van Den Berghe G; Vincent MF
    Am J Hum Genet; 2004 Jun; 74(6):1276-81. PubMed ID: 15114530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate enhances the antianabolic and antiproliferative effects of 5-aminoimidazole-4-carboxamide riboside.
    Beckers A; Organe S; Timmermans L; Vanderhoydonc F; Deboel L; Derua R; Waelkens E; Brusselmans K; Verhoeven G; Swinnen JV
    Mol Cancer Ther; 2006 Sep; 5(9):2211-7. PubMed ID: 16985054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?
    Corton JM; Gillespie JG; Hawley SA; Hardie DG
    Eur J Biochem; 1995 Apr; 229(2):558-65. PubMed ID: 7744080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of ATIC as a Novel Target for Chemoradiosensitization.
    Liu X; Paila UD; Teraoka SN; Wright JA; Huang X; Quinlan AR; Gatti RA; Concannon P
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):162-173. PubMed ID: 29029884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between 5-aminoimidazole-4-carboxamide-ribotide and AMP-activated protein kinase activity in the perfused mouse heart.
    Zhang L; Frederich M; He H; Balschi JA
    Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1235-43. PubMed ID: 16258030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasticity in the purine-thiamine metabolic network of Salmonella.
    Bazurto JV; Downs DM
    Genetics; 2011 Feb; 187(2):623-31. PubMed ID: 21135073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of AICAR transformylase/IMP cyclohydrolase (ATIC) from Staphylococcus lugdunensis.
    Verma P; Kar B; Varshney R; Roy P; Sharma AK
    FEBS J; 2017 Dec; 284(24):4233-4261. PubMed ID: 29063699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report of a rare purine synthesis disorder due to 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase (AICAR) deficiency.
    Joy P; Madhuri V; Palocaren T; Das S; Susan Cleave Abraham S; Korula S; Koshy B; Jose J; Chandran M; Danda S
    Brain Dev; 2022 Oct; 44(9):645-649. PubMed ID: 35637059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.
    Boccalatte FE; Voena C; Riganti C; Bosia A; D'Amico L; Riera L; Cheng M; Ruggeri B; Jensen ON; Goss VL; Lee K; Nardone J; Rush J; Polakiewicz RD; Comb MJ; Chiarle R; Inghirami G
    Blood; 2009 Mar; 113(12):2776-90. PubMed ID: 18845790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor α-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated protein kinase-independent.
    Bumpus NN; Johnson EF
    J Pharmacol Exp Ther; 2011 Dec; 339(3):886-95. PubMed ID: 21896918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.